Viewing Study NCT00410566


Ignite Creation Date: 2025-12-24 @ 4:04 PM
Ignite Modification Date: 2025-12-25 @ 7:29 PM
Study NCT ID: NCT00410566
Status: TERMINATED
Last Update Posted: 2015-03-19
First Post: 2006-12-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Study of rhASM Enzyme Replacement Therapy in Adults With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease)
Sponsor: Genzyme, a Sanofi Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module